OCEA Wutah pendapatan triwulanan Ocean Biomedical

Logo grafis Ocean Biomedical Inc (OCEA)

Ocean Biomedical, Inc. (OCEA) is expanding its margins through the commercialization of immunological breakthroughs and B2B partnerships. Quarterly revenue growth statistics clearly demonstrate the pace of expansion, where 0.00 represents the current level of this metric. Demand for cancer therapy remains independent of economic cycles, although pipeline development relies on venture capital. Growth prospects are driven by future licensing agreements with pharmaceutical behemoths.

OCEA (Ocean Biomedical Inc) riwayat Tingkat wutah pendapatan sajrone kuartal saka 28.04.2023 nganti 24.05.2025

Rincian metrik keuangan lan pasar Ocean Bio (OCEA)

- kuotasi saiki lan rata-rata prakiraan nilai:
Analisis umum perusahaan:Ocean Biomedical, Inc. (OCEA)
Produk seri Ocean Biomedical Inc

Ocean Biomedical, Inc. (OCEA) investments in energy efficiency and the ecological modernization of laboratories establish a foundation for the sustainable scaling of its oncology business. An analysis of the quarterly revenue chart on GURU.Markets allows for an assessment of the recovery speed of commercial flows by calculating three-month sales growth rates, which is critical for determining the company's ability to withstand external shocks and confirming the viability of its business model.

Analisis pesaing Ocean Biomedical, Inc.

argenx BVBA - Wutah pendapatan triwulanan|BNTX: Wutah pendapatan kuartal marang kuartal|ABVX: Wutah pendapatan triwulanan|Wutah dodolan kuartal marang kuartal ADMA|Wutah pendapatan kuartal marang kuartal protagonist-inc.com|Wutah dodolan triwulanan Immunovant, Inc. (IMVT)|Wutah pendapatan triwulanan KNSA|GRFS: Dinamika pendapatan kuartal marang kuartal|Adaptive Biotechnologies - Wutah dodolan triwulanan|CLDX: Wutah dodolan kuartal marang kuartal|Aurinia Corp - Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal BioCryst Corp|VERA: Wutah pendapatan triwulanan|dianthustx.com (DNTH) - Wutah pendapatan triwulanan|PHVS (Pharvaris NV) - Wutah pendapatan triwulanan|ABCL: Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal Tourmaline Bio, Inc. (TRML)|PGEN (Intrexon) - Tambahing pendapatan triwulanan|Wutah pendapatan triwulanan PHAR (Pharming Corp)|nektar.com (NKTR) - Tingkat wutah pendapatan sajrone kuartal|UPB - Wutah pendapatan kuartal marang kuartal|Tambahing pendapatan triwulanan ZBIO (Zenas Biopharma)|IMNM: Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal Gossamer Bio, Inc. (GOSS)|Wutah pendapatan kuartal marang kuartal KalVista Pharmaceuticals|Septerna Inc (SEPN) - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan triwulanan PVLA|SVRA (Savara) - Tambahing pendapatan triwulanan|Rigel Pharma - Wutah dodolan triwulanan|Tingkat wutah dodolan sajrone kuartal AnaptysBio Corp (ANAB)|ATXS: Wutah dodolan triwulanan|Tambahing pendapatan triwulanan ENGN (enGene Holdings Inc.)|RAPT Therapeutics Inc. (RAPT) - Wutah pendapatan kuartal marang kuartal|Aerovate Therapeutics Inc (JBIO) - Wutah pendapatan triwulanan|ACRS (Aclaris Therapeutics, Inc) - Wutah pendapatan triwulanan|Kyverna (KYTX) - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan triwulanan TLSA|Wutah dodolan triwulanan Cabaletta Bio, Inc. CABA|Ventyx Biosciences - Wutah dodolan triwulanan|THTX: Wutah dodolan kuartal marang kuartal|AVTX - Wutah pendapatan kuartal marang kuartal|ELDN: Wutah pendapatan kuartal marang kuartal|Agenus Inc. (AGEN) - Wutah pendapatan kuartal marang kuartal|Wutah dodolan triwulanan Climb Bio Inc|ZURA (Zura Bio Ltd) - Wutah pendapatan triwulanan|Wutah pendapatan triwulanan aTyr Pharma Inc|Wutah pendapatan triwulanan ADAG|Tingkat wutah dodolan sajrone kuartal ImageneBio|Wutah pendapatan triwulanan STTK (Shattuck Labs Inc)|Wutah pendapatan triwulanan Equillium, Inc. EQ|CNTB - Wutah pendapatan kuartal marang kuartal|Immunic Therapeutics (IMUX) - Wutah dodolan triwulanan|ATRA: Wutah pendapatan triwulanan|InflaRx GmbH (IFRX) - Wutah pendapatan triwulanan|XFOR (x4pharma.com) - Wutah pendapatan triwulanan|Wutah pendapatan triwulanan Adicet Bio|Wutah pendapatan kuartal marang kuartal Celularity Inc (CELU)|Wutah dodolan triwulanan INmune Bio Corp INMB|Wutah pendapatan kuartal marang kuartal Barinthus Biotherapeutics plc BRNS|KZR - Wutah dodolan triwulanan|sabbiotherapeutics.com - Wutah pendapatan triwulanan|akaritx.com (AKTX) - Wutah dodolan triwulanan|ENLV: Wutah pendapatan triwulanan|QTTB (Q32 Bio Inc) - Wutah pendapatan kuartal marang kuartal|GOVX (geovax.com) - Wutah pendapatan triwulanan|Wutah pendapatan triwulanan Edesa Biotech Corp|Wutah pendapatan triwulanan IBIO|Wutah dodolan triwulanan Carisma Tx CARM|Wutah pendapatan kuartal marang kuartal XTL Biopharmaceuticals Ltd XTLB|Wutah pendapatan triwulanan Bolt Biotherapeutics BOLT|HCW Biologics - Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal aptevotherapeutics.com|AIM (AIM ImmunoTech, Inc.) - Wutah dodolan triwulanan|Aditxt Corp - Tambahing pendapatan triwulanan|GRI (GRI Bio Inc) - Wutah pendapatan triwulanan|Wutah pendapatan triwulanan XORTX Therapeutics Inc|Wutah pendapatan kuartal marang kuartal Vyome Therapeutics (HIND)|REVB - Tingkat wutah pendapatan sajrone kuartal|Wutah pendapatan kuartal marang kuartal Indaptus Therapeutics, Inc. INDP|Wutah pendapatan triwulanan scinai.com SCNI|CalciMedica Inc - Wutah pendapatan triwulanan|AFMD - Wutah pendapatan triwulanan|ALLK: Wutah pendapatan triwulanan|Dinamika pendapatan kuartal marang kuartal HOOK (HOOKIPA Pharma, Inc.)|IGMS (IGM Biosciences) - Wutah pendapatan triwulanan|ITOS: Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal TC Biopharm (TCBP)|THRD (Third Harmonic Bio Inc.) - Tambahing pendapatan triwulanan